2. UroToday Home
  3. Video Lectures

Prostate Cancer Videos

Implementation of the PC360 Algorithm to Manage Cardiovascular and Bone Health Risks on ADT - Jason Hafron
PROTEUS Trial: Neoadjuvant Apalutamide and Androgen Deprivation Therapy in High-Risk Localized Prostate Cancer - Mary-Ellen Taplin
Hydrogel Spacer Placement for Prostate Radiotherapy: A Urology Residency Training Experience - Zachary Klaassen
PEACE-2 Trial of Cabazitaxel with ADT and Radiotherapy in Very High-Risk Localized Prostate Cancer - Karim Fizazi
Survey Results on Prostate Cancer Management Treatment Preferences in South Asia - Vedang Murthy
Nutritional Counseling for Prostate Cancer Patients Receiving Systemic Therapy - Maria De Santis
Testosterone Recovery Dynamics After Short-Term ADT for Localized Prostate Cancer - Bertrand Tombal
Balancing Treatment Intensification and Quality of Life in Elderly Prostate Cancer Patients - Rana McKay
Genomic Classifiers and AI for Personalizing Prostate Cancer Radiation Therapy - Jason Efstathiou
Comparing Risk Models to Guide Biopsy Decisions for Intermediate Prostate MRI Findings - Nathan Perlis
ADT Class and Cardiovascular Risk: A Large Retrospective Analysis in Prostate Cancer - Andrew Hahn
Machine Learning Models Aim to Quantify Vulnerability in Geriatric Oncology Patients - Sarah Psutka
Radium-223 Monotherapy Explored in PSMA-Positive Bone Lesions Without Conventional Imaging - Melissa Abel
Rectal Spacers in Prostate Radiotherapy: Balancing Efficacy, Safety, and Patient Experience - Michael Greenberg & Daniel Welchons
Cluster-Randomized Trial Targets Barriers to Mainstream Germline Testing for Veterans - Daniel Kwon
Co-PSMA Trial Explores Tracer for Detecting Recurrence After Radical Prostatectomy - Louise Emmett
The Co-PSMA Trial: Comparing PSMA PET Tracers in Biochemically Recurrent Prostate Cancer - Louise Emmett
Combining PSMA PET and Genomic Risk Assessment in High-Risk Prostate Cancer - Sophia Coraci
Salvage Radiotherapy Intensification Tested in Men with High-Risk Biochemical Recurrence - Edwin Posadas
REVELUTION Trial: A Comparative Study of GnRH Agonist and Antagonist on Coronary Plaque in Prostate Cancer - Sagar Patel
Balancing MRI Sensitivity and Specificity in Prostate Cancer Staging - Georgios Agrotis
Study Examines the Path to Proficiency in Prostate MRI Interpretation for Trainees - Dominik Deniffel & Thomas Herrmann
Phase 3 INDICATE Trial for Patients with Biochemically Recurrent Prostate Cancer - Neha Vapiwala
Analysis of a Posterior Surgical Technique in Robotic Assisted Radical Prostatectomy - Jim Hu
Study Investigates an AI-Powered Prognostic Test in Salvage Radiation Therapy Patients - Paul Nguyen
Coronary Atherosclerosis Findings from the REVELUTION Trial of Leuprolide and Relugolix - Avirup Guha & Sagar Patel
LUNAR Trial: Neoadjuvant Lutetium-PSMA Plus SBRT Evaluated in Oligometastatic Prostate Cancer - Amar Kishan & Jeremie Calais
Implementing Systemic Biomarker Testing for Metastatic Prostate Cancer Patients - Pedro Barata
DADSPORT Meta-Analysis Reports on Hormone Therapy with Post-Prostatectomy Radiotherapy - David Fisher
A Global Investigation into the Drivers of Cancer Care Disparities - Edward Christopher Dee
PRESTO Trial Final Results for High-Risk Biochemically Recurrent Prostate Cancer - Rahul Aggarwal
Preclinical Study Evaluates p300 Protein in AR-Driven Prostate Cancer - Jie Luo
AI Applications in Prostate Cancer Pathology and Prognostics - Tamara Lotan
The Role of the Gut Microbiome in Prostate Cancer - Karen Sfanos
Rectal Spacer Use Leads to Better Patient-Reported Bowel and Sexual Outcomes - Daniel Song
Study of PSA Testing Perceptions Among Black Patients and Their Physicians, Journal Club - Rashid Sayyid & Zachary Klaassen
Using an AI-Generated Avatar to Deliver Pre-Visit Patient Counseling - Avi Baskin
ERSPC 23-Year Update: Long-Term Benefits of PSA Screening - Monique Roobol
Patient-Reported Outcomes in the NRG-GU005 Prostate Cancer Trial - James Yu
NRG-GU005 Trial Compares SBRT and Hypofractionated IMRT for Prostate Cancer - Rodney Ellis
Early-Phase Study Investigates Copper-61 PSMA PET for Prostate Cancer Imaging - Gary Ulaner
Evaluating the Use of Lymph Node Dissection During Radical Prostatectomy - Fernando Pablo Secin & Juan Carlos Vélez Román
Considerations for Renaming Indolent Prostate Cancer in Different Practice Settings - Matthew Cooperberg & Nicolás Villareal Trujillo
Review of Transperineal and Transrectal Prostate Biopsy Outcomes - Beyond the Abstract
Factors Associated with Recovery of Urinary Continence: A Multicenter Comparison of Pelvic Fascia-sparing and Standard Robotic-assisted Radical Prostatectomy - Beyond the Abstract
The Use of a Long-Axial PET Scanner for PSMA Imaging in Prostate Cancer - Rodney Hicks
Review of the Unfold AI Platform for Localized Prostate Cancer Assessment - Geoffrey Sonn
Elevating the Patient Voice: Understanding Treatment Preferences in Patients with Advanced Prostate Cancer - Beyond the Abstract
First Cross-Continent Robotic Prostatectomy Performed Using Tele-Surgery - Vipul Patel
CAN-2409 + Radiation Improves Disease-Free Survival in Prostate Cancer Patients - Angela Jia
Radiopharmaceutical Therapies: Safety, Education, and Collaboration in Oncology - Heather Jacene & Neha Vapiwala
Helen Barr Memorial Scholarship Aims to Grow Radiation Oncology Interest - Mitchell Finkelstein
Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients - Amy Shaver
Delayed Genomic Testing Limits Access to Life-Prolonging Cancer Treatments - Chadi Hage Chehade
Persistent PSA After Prostatectomy: Timing and Mortality Risk Implications, Journal Club - Rashid Sayyid & Zachary Klaassen
AI Model Identifies STAMPEDE Patients Needing Treatment Intensification - Nicholas James
Multimodal AI Test Predicts Prostate Cancer Metastasis and Treatment Response - Timothy Showalter
Surgical Outcomes in High-Risk Prostate Cancer: PSMA-PET vs Conventional Imaging - Alessandro Viti
Clinical Trial Access Barriers for Veterans with Prostate Cancer - Madison Krischak
Optimizing Prostate Biopsy Specimens for Improved Pathological Diagnosis - Daniel Wiener
The Details Are in the Core: Advancing Prostate Tissue Collection - James Wysock
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients? - Beyond the Abstract
Evaluating the Importance of Practice-Level Factors on Adherence to Prostate Cancer Treatment Guidelines in Urology
CDK12 Loss Drives Prostate Cancer Progression and Creates Therapeutic Vulnerability - Jean Tien
ONECUT2 Crystal Structure Reveals Potential for Targeted Prostate Cancer Therapy - Brad Gallent
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes - Marina Sharifi
Dietary Pro-Oxidant Menadione in Prostate Cancer Treatment - Lloyd Trotman
Androgen Receptor Inhibition and MHC Class 1 Expression in Prostate Cancer - Lisa Chesner
PORTOS Biomarker Guides Radiation Dose Escalation in Prostate Cancer Treatment - George Zhao & Alan Dal Pra
Lineage-Specific EZH2 Activity in Advanced Prostate Cancer Subtypes - Varadha Balaji Venkadakrishnan
Intratumoral Heterogeneity Drives Therapy Resistance in Metastatic Prostate Cancer - Laura Sena
Canonical Androgen Response Elements in Prostate Cancer Growth Suppression - Christopher Barbieri
CDK12 Mutation Types and PARP Treatment Effectiveness - Jonathan Chou
Prostate Cancer Disparities: A Global Lens - Edward Christopher Dee
Universal Germline Genetic Testing for Prostate Cancer Patients - Neal Shore & Sarah Young
Urinary Incontinence in Gay and Bisexual Prostate Cancer Survivors - Kristine Talley
Transportation Barriers in Prostate Cancer Care: Addressing Racial and Geographic Disparities - Quoc-Dien Trinh & Muhieddine Labban
Study Uncovers AR-Positive Stromal Cells’ Role in Prostate Cancer Microenvironment - Ece Eksi
MYC’s Role in Prostate Cancer Immune Suppression and Progression - Mindy Kim Graham
The Proteogenomics of Prostate Cancer Radioresistance - Roni Haas
Heterogeneous Genetic Architectures of Prostate Cancer Susceptibility in Sub-Saharan Africa - Timothy Rebbeck
How Do We Maximize Use of Radiotherapy for Prostate Cancer in Africa "Presentation" - Omolara Aminat Fatiregun
Dealing with Inequalities: What Can We Learn from the Indian Healthcare System? "Presentation" - Vedang Murthy
Medicare Part D 2025 Reduces Out-of-Pocket Costs for Oral Prostate Cancer Treatments - David Morris
Impact of a Rash Management Guide in Patients Receiving Apalutamide for High-Risk Localized Prostate Cancer in the Apa-RP Study - Beyond the Abstract
NSD2's Role in Prostate Cancer: Uncovering AR's Functional Duality - Abhijit Parolia
Artificial INtelligence to Support Informed DEcision-making (INSIDE) for Improved Literature Analysis in Oncology - Beyond the Abstract
MAST Trial Finds Metformin Ineffective in Preventing Prostate Cancer Progression - Neil Fleshner
VA's Million Veterans Program Reveals Crucial Genetic Data for Prostate Cancer Treatment - Bruce Montgomery
BRCA2 and Beyond: Unraveling Genetic Drivers of Prostate Cancer Aggressiveness - Hiba Khan
Discussion Between Expert Clinicians and Patients on the EMBARK Trial, A Journal Club for Patients with Prostate Cancer - Matthew Cooperberg
EMBARK Trial: Enzalutamide Monotherapy & Combination Therapy for High-Risk Prostate Cancer - Stephen Freedland, Neal Shore & Rana McKay
ZNF397 Deficiency: A Key Driver of Lineage Plasticity in Prostate Cancer Therapy Resistance - Ping Mu
Advancing Prostate Cancer Research: The MDA PCa PDX Program - Estefania Labanca
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems - Isla Garraway
Hypofractionation in Prostate Cancer Radiotherapy: Balancing Efficacy and Safety - Neha Vapiwala
SLICE: Revolutionizing Surgical Training with Ultra-Realistic Simulation - Ahmed Ghazi
Redefining Low-Volume Metastatic Prostate Cancer in the Era of PSMA PET Imaging - Oliver Sartor
Moonshot Initiative Funds Study on PSA-Based Risk-Stratified Prostate Cancer Screening - Siobhan Sutcliffe
Predicting Response to Hormone Therapy in Prostate Cancer With a Post-Prostatectomy MMAI Model - Todd Morgan
HSD3B1 Adrenal-Permissive Allele Linked to Worse Prostate Cancer Outcomes in VA Health System Study - Rana McKay
Evaluating a Sequential Screening Approach for Prostate Cancer Using PSA, Kallikrein Panel, and MRI in the ProScreen Trial, Journal Club - Rashid Sayyid & Zachary Klaassen
Value-Based Payment Models and Management of Newly Diagnosed Prostate Cancer - Avinash Maganty
The Adrenal Permissive HSD3B1 Allele: A Decade-Long Journey from Initial Discovery to Proven Clinical Significance in Prostate Cancer - Nima Sharifi
Staging High-Risk Prostate Cancer with PSMA PET: Strengths and Pitfalls - Irene Burger
Local Therapy in mHSPC: Who Does Really Benefit? - Alberto Bossi
A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy - Beyond the Abstract
Novel 18-Gene Urine Test Improves Detection of Clinically Significant Prostate Cancer - Jeffrey Tosoian
A US Real-World Study of Treatment Patterns and Outcomes in Localized or Locally Advanced Prostate Cancer Patients - Beyond the Abstract
The Lancet Commission on Prostate Cancer - Nicholas James & James N'Dow
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes - Nicholas Zorko
CEASAR Study Reveals Long-Term Quality of Life Outcomes for Localized Prostate Cancer Treatments - Daniel Barocas & Bashir Al Hussein Al Awamlh
Representation Matters: Trust in Digital Health Information Among Black Patients with Prostate Cancer - Stacy Loeb
The STEEL Trial: Evaluating Enzalutamide Plus ADT with Salvage RT for High-Risk Recurrent Prostate Cancer - Edwin Posadas
Prostate Cancer Risk Variants Identified in Expanded Multi-Ancestry GWAS Meta-Analysis - Anqi Wang
Plant-Based Diet Associated with Better Quality of Life in Prostate Cancer Survivors - Stacy Loeb
Novel Computational Approach Identifies NME2-MYC Axis as Biomarker and Therapeutic Target in Enzalutamide-Resistant CRPC - Antonina Mitrofanova
Novel Hormone Therapy and Coordination of Care in High-Risk Biochemically Recurrent Prostate Cancer - Beyond the Abstract
Unmet Sexual Health Resource Needs and Preferences for Interventions to Address These Needs Among Female Partners of Patients with Prostate Cancer - Natasha Gupta
The Impact of Screening Practices for Black Men - Leanne Woods-Burnham
The De-Escalate Trial: Intermittently Stopping Prostate Cancer Treatments to Improve Quality of Life - Guillaume Grisay
Advancing Personalized Medicine: Examining Trop2 as a Biomarker to Stratify Prostate Cancer Patient Risk - Tanya Stoyanova
High-Risk Prostate Cancer: 80Gy + ADT Extends Survival Without Added Toxicity - Christophe Hennequin
The Impact of Advanced Imaging on Detection and Treatment in Nonmetastatic CRPC - Vahan Kassabian
Highlighting APCCC 2024: An International Prostate Cancer Meeting - Silke Gillessen & Aurelius Omlin
Addressing the Intersection of Climate Change and Cancer: A Roadmap to Action for Urological Care Providers - Alexander Cole
Navigating the Nuances: Exploring Imaging Options and Impact to Treatment Strategies in nmCRPC - Ryan Malone
Comprehensive Multi-Region Sampling Reveals Extensive Genomic Heterogeneity in Metastatic Prostate Cancer - Alexander Wyatt
Prostate Cancer Cell Metabolism Dictates Differentiation and Therapy Response - Andrew Goldstein
Targeting Myeloid Chemotaxis to Reverse Prostate Cancer Therapy Resistance - Johann De Bono
How UBE2J1 Impacts Anti-Androgen Resistance in Prostate Cancer - Ping Mu
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer - Beyond the Abstract
Study Reveals African Ancestry Gene Variant Strongly Linked to Highly Aggressive Forms of Prostate Cancer - Mayuko Kanayama
Research Reveals How Metabolic Rewiring Enables "Persister" Cancer Cells to Resist Death and Treatment - Asmaa El-Kenawi
Novel Research Illuminates How CXCR7 Protein Interactions Promote Growth of Neuroendocrine Prostate Cancer - Jindan Yu
Decoding the Metabolic Shift Behind Prostate Cancer Drug Resistance - Andrew Goldstein
How Chemotherapy Drives Metastasis By Causing Tumor Cells to Become Significantly More Mobile - Sarah Amend
Retrospective Study Shows Anticholinergics and PDE5 Inhibitors Not Tied to Increased Dementia Risk in Prostate Cancer Patients - Avery Braun
The Complex Interplay of Factors Driving Prostate Cancer Disparities - Steven Patierno
Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer - Gerhardt Attard
How AI and Machine Learning Are Revolutionizing Prostate Cancer Diagnosis - Tamara Lotan
INDICATE Trial Seeks to Clarify Role of PET Scans in Prostate Cancer Recurrence - Neha Vapiwala
LuTectomy Study Shows Promise: Targeted Radiation Safe Before Prostate Cancer Surgery - Michael Hofman & Renu Eapen
The Complex Web of SPOP Mutations and STING1 Signaling in Prostate Cancer - Patrick Pilié
Broadening Treatment Horizons with CDK4/6 Inhibitors from Breast to Prostate Cancer - Rana McKay
The Critical Intersection of Androgen Receptor Pathways and Cell Cycle Regulation in Prostate Cancer Therapy - Rana McKay
The Current Treatment Landscape in Metastatic Hormone-Sensitive Prostate Cancer - Andrew Armstrong
Treatment Decision Making in mHSPC: The Medical Oncologist and Patient “What the Patient Needs to Know” About this Disease and Treatment Options? - Brenda Martone
The Hidden Mechanisms Behind Rapid Tumor Evolution: AR Amplification on Extrachromosomal DNA I Prostate Cancer - Scott Dehm
Strategically Targeting Lactate in Prostate Cancer: Clinical Insights into Tumor Control and the Development of Next-Generation Therapeutics - Akash Patnaik
The Evolution of PSMA Theranostics: A 30-Year Journey with the Prostate Cancer Foundation - Andrea Miyahira
Historical Versus Contemporary Practices: An In-Depth Analysis of Surgical Outcomes in Prostate Cancer - Udit Singhal
UCSD and the Prostate Cancer Foundation Unveil Second Annual Patient Summit: What to Expect - Rana McKay
Influencing Best Practices for Genomic and Germline Testing in Urology - Abhishek Srivastava
AI-Based PTEN Loss Assessment: A Multicenter Retrospective Study on Prostate Cancer Metastasis - Tamara Jamaspishvili
How Multiparametric MRI is Revolutionizing Lymph Node Dissection in Prostate Cancer - Alberto Martini
Sexual Health and Treatment-Related Sexual Dysfunction in Sexual and Gender Minorities with Prostate Cancer - Daniel Dickstein
Intrapatient Heterogeneity in Prostate Cancer: A Deep Dive into Androgen Receptor Alterations - Gerhardt Attard
RESPOND Study: A Multi-Faceted Exploration into Prostate Cancer's Racial Disparities - Scarlett Lin Gomez
The Impact of 'Sneaky Testosterone' on Post-Prostatectomy Treatment - Nima Sharifi
Translational Regulation in Prostate Cancer: The Akt/mTOR and MNK/eIF4E Pathways Unveiled - Daniela Brina
Fear of Saying No (FOSNO): Setting Boundaries With Our Patients and Ourselves - Monica Chatwal
Club-Like Cells in Proliferative Inflammatory Atrophy of the Prostate - Karen Sfanos
The Role of Healthy Lifestyles in Prostate Cancer - June Chan & Rebecca Graff
Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images - Tamara Lotan
Loss of SYNCRIP Unleashes APOBEC-Driven Mutagenesis, Tumor Heterogeneity and AR-Targeted Therapy Resistance in Prostate Cancer - Ping Mu
Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer - Sarah Young & David Wise
The UroTarget Conference: A Meeting of Medical Minds in Argentina - Federico Losco
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry - Burcu Darst
The Emotional Toll of Surgical Complications - Scott Eggener
A Mechanism of Tumor Suppression: Unveiling Transcription-Translation Conflict - Andrew Hsieh
Targeting Advanced Prostate Cancer with STEAP1 Chimeric Antigen Receptor T Cell and Tumor-Localized IL-12 Immunotherapy - John Lee
A Faith-Based Approach to Prostate Cancer Screening and Clinical Trial Recruitment - Pastor Daniel Simmons
Predicting Treatment Response in Prostate Cancer: The Power of Spatial Proteomic Approaches - Christina Curtis
A Deep Dive into Patient Experiences in Prostate Cancer Clinical Trials - Ravi Madan
The Radiopharmaceutical Revolution: New Frontiers in Prostate Cancer Treatment - Oliver Sartor
Prostate Cancer and Veterans Health: A Spotlight on the Initiatives at the VA System - Hiten Patel
Patient-Driven Webtool Challenges Traditional Counseling in Prostate Cancer Germline Testing - Veda Giri
Association of Plant-Based Diet Index with Quality of Life in Patients with Prostate Cancer - Stacy Loeb
Cancer Care's Hidden Burden: Linking Financial Stress and Mortality in Cancer Treatment - Hiba Khan
Practice Competition and Treatment of Newly Diagnosed Patients with Prostate Cancer - Avinash Maganty
Genomic Alterations and Self-Reported Agent Orange Exposure in United States Veterans with Metastatic Prostate Cancer - JJ Haijing Zhang
Innovation in Prostate Cancer Care: Frailty, Bone Health, and Cardiovascular Screening - Ravi B. Parikh
DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - Neal D. Shore
Prostate Cancer Survivorship Today: Support that Spans the Journey - Alicia Morgans
Harnessing Exercise to Improve Outcomes in Black Prostate Cancer Patients - Dong-Woo (Derek) Kang
Interpreting EMBARK Trial Results: Intensified Treatment and Hormone Therapy in High-Risk Patients - Christian Gratzke
Targeting Tumor-Induced Neutrophil Senescence: A Novel Approach to Treating Prostate Cancer - Arianna Calcinotto & Nicolo Bancaro
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients - Randy A. Vince
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes - Gavin Ha
Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018 - Bashir Al Hussein Al Awamlh
Enhancing Precision Oncology for Veterans through VA's Strategic Partnerships - Isla P. Garraway
Trends in Prostate Cancer Diagnosis in Transgender Women - Farnoosh Nik-Ahd
Unveiling the Role of Rb Gene in Prostate Cancer: BET Inhibitors and Immunotherapy - Akash Patnaik
The Importance of Implementing Psycho-Oncology Into Prostate Cancer Survivorship - Cristiane Bergerot
Dissecting the Dynamics of the Tumor Microenvironment: Nutrient Availability and Treatment Outcomes - Asmaa El-Kenawi
Overview of the Decipher® Genomic Classifier
Report from the 2022 Coffey-Holden Prostate Cancer Academy Meeting - Kenneth Pienta, Andrea Miyahira, & Howard Soule
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men - Jonathan Shoag
A Toast to Hope: A Journey of Wine Making and Prostate Cancer Advocacy - Robert Hollander
Neurocognitive Impairment Associated with Traditional and Novel AR Signaling Inhibitors ± Androgen Deprivation Therapy - a Pharmacovigilance Study - Logan Briggs
Peer-Led Support Groups for Prostate Cancer Patient Care - Herbert Geller
Fueling Wellness with Flavor for Cancer Patients: The Wellness Principles - Gary Deng
Biology and Prostate Cancer: Elucidating Differential Androgen Receptor Cistromes in African American vs. European American Men - Jacob Berchuck
ctDNA: A New Window into Prostate Cancer's Progression and Chronology of Treatment-Resistance - Alexander Wyatt
Innovative Design and Real-World Validation: The STAMPEDE Trial for Prostate Cancer - Noel Clarke
From Blood to Diagnosis: the Role of ctDNA in Prostate Cancer Treatment - Alexander Wyatt
Exploring Molecular Drivers and Predictive Biomarkers of Prostate Cancer Heterogeneity - Marzia Del Re
The Role of Tumor Immune Response in Castration-Resistant Prostate Cancer - Andrea Alimonti
The Ups and Downs of One Man's Prostate Cancer Battle - Julio Pelaitai
Exercise and Activity Aids Man’s Recovery and Outlook After Prostate Cancer - Ignacio Calderón Balanzátegui
Advances in Precision Medicine Rapidly Transforming Treatment Options for Bladder Cancer Patients - Daniel Castellano
Female Oncologist Bridges Divide in Male-Dominated Urology Field - Gabriela Gatica
Interdisciplinary Uro-Oncology Conference Convenes in Mendoza - Mauricio Fernández Lázaro
The Evolving Role of Urology in Multidisciplinary Cancer Care Teams - Gustavo Villoldo
UroTarget Conference: Driving Advances in Multidisciplinary Uro-Oncology Care in Latin America - Cecilia Atencio
Genitourinary Oncology in Latin America: Challenges, Progress, and Collaboration - Juan Pablo Sade
Barriers to Genitourinary Cancer Research in Latin America - Martín Ángel
Vineyard Owner's Inspiring Outlook While Battling Metastatic Prostate Cancer - Rolando Porolli
Finding Meaning and Resilience in the Face of Advanced Prostate Cancer - Ángel
Genomic Comparison Between African American Men & European American Men with Prostate Cancer - Isra Elhussin
Battling Prostate Cancer with Optimism and Perseverance - Hugo Mercado
The Prostate Cancer Foundation VA Health Initiatives, Executing Precision Oncology within the VA - Matthew Rettig & Isla Garraway
Exploring the Potential of Lutetium PSMA in High-Risk Localized Prostate Cancer: The LuTectomy Trial - Renu Eapen
Addressing Prostate Cancer Health Disparities - Leanne Woods-Burnham
Longitudinal Patient Sampling and Immune Profiling in Oligometastatic Prostate Cancer - Sophia Kamran
Scaling Up Point-of-Care Genetic Testing in the VA: A Nurse-Led Initiative - Kara Maxwell
Exploring the Nuances of the PRONOUNCE Trial - Celestia Higano
PROCLAIM Study Reveals Impact of Germline Genetic Testing on Prostate Cancer Clinical Decisions - Neal Shore
Navigating the Challenges of Somatic Mutation Testing in Prostate Cancer - Joaquin Mateo
Personalizing Prostate Cancer Care with AI - Felix Feng
Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment APCCC 2022 Presentation - Eric Small
Emerging Therapies and Therapeutic Targets in Prostate Cancer - Mark Rubin
MRI and Active Surveillance for Prostate Cancer - Robert Reiter
A Probing Conversation on Prostate Cancer Diagnosis and the Potential of Liquid Biopsies and Polygenic Risk Scores - Sanoj Punnen
Ironman Registry: Pioneering Data Collection and Biomarker Analysis in Prostate Cancer Research Daniel George
Management of pN1 Prostate Cancer (Including Systemic Therapy) APCCC 2022 Presentation - Derya Tilki
Outcomes of the ARASENS Trial by Metastatic Subtype - Bertrand Tombal
Immunotherapy and PARP Inhibitors in Biochemical Recurrent Prostate Cancer - Alexandra Sokolova
How Does the Data from the PEACE-1, ARASENS and ENZAMET Studies Inform Clinical Practice? - Karim Fizazi
The ENACT Trial: Ezalutamide Monotherapy plus Active Surveillance vs Active Surveillance Alone in Patients with Low-Risk or Intermediate-Risk Prostate Cancer - Neal Shore
The EMBARK Study: A Phase 3 Randomized Study of Enzalutamide Plus Leuprolide and Enzalutamide Monotherapy in High-Risk Nonmetastatic Hormone-Sensitive Prostate Cancer with Rising PSA After Local Therapy - Stephen Freedland
Incorporating Molecular Testing into Clinical Practice for Prostate Cancer - Elena Castro & Colin Pritchard
Fast Facts: The Importance of Genetic Testing in Prostate Cancer - Brittany Szymaniak
Patient-Centric Approaches: The Urgent Need for Genetic Testing in Prostate Cancer - Brittany Szymaniak
Advancing Genetic Testing in Metastatic Prostate Cancer - Brenda Martone
Treatment with Radium-223 and Effects on Bone Health in Patients with mCRPC - Fred Saad
Systemic Treatment in the Context of Salvage Radiation and Biochemical Recurrence - Piet Ost
The Conundrum of Systemic Salvage Therapy at the Time of Salvage Radiation Therapy - Brandon Mahal
Novel Approaches in the Management of High-Risk Prostate Cancer - Ray Manneh Kopp
Demystifying PSMA Theranostics: A Discussion on Implementing Lutetium-177 Treatment - Oliver Sartor
Beyond Clinical Trials: Mastering Patient Care for Lutetium-PSMA-617 Therapy - Michael Morris
Treatment Delay Experiences Among Black and White Men with Prostate Cancer - Bhav Jain & Christopher Dee
The Addition of Docetaxel to Radiotherapy and ADT in Nonmetastatic Unfavorable-Risk Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
Radiopharmaceuticals in Prostate Cancer: A Deep Dive into Patient-Reported Outcomes - Scott Tagawa
Case-Based Discussions Illuminate the Complexities of Oligometastatic Prostate Cancer Treatment - Phuoc Tran
Should Checkpoint Inhibitors Ever Be Used Outside of a Clinical Trial in Prostate Cancer - James Gulley
Can We Make Any More Progress Targeting the Androgen - Androgen Receptor Interaction - Nima Sharifi
Clinical Implications of the Study Findings from the Radiotherapy Adjuvant Versus Early Salvage ((TROG 08.03/ANZUP RAVES) Trial - Andrew Kneebone and Declan Murphy
MRI Versus Ultrasound for Prostate Cancer - Samir Taneja
The Relationship Between Surgeon Age and Post-Operative Outcomes - Raj Satkunasivam, Zachary Klaassen, Christopher Wallis
Urinary Symptoms Post-Prostatectomy Case Study - Diane Newman
Treating Post Prostatectomy Incontinence - Diane Newman
Outpatient Trans-Rectal MR-Guided Laser Focal Therapy Phase II Clinical Trial: 10-Year Interim Results - John Feller
Focal Therapy in Prostate Cancer - Art Rastinehad
The Evolution of Care: Focal Therapy for Prostate Cancer: Tom Polascik
Transrectal vs Transperineal - Matthew Allaway
The Impact of Vitamin D and Statins on Prostate Cancer Outcomes - Lorelei Mucci and Elizabeth Platz
Prostate 8 Program - Lifestyle, Exercise, and Nutrition - Stacey Kenfield
"Eat, Move, Sleep" - June Chan
Increasing Rates of Active Surveillance as the Standard of Care in Men with Low Risk Prostate Cancer- Matthew Cooperberg
Patient-reported Outcomes from TITAN: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer - Neeraj Agarwal
Gold Nanoparticles Used in Photothermal Therapy for Prostate Tumors- Art Rastinehad
Core Concepts for Prostate Cancer Care from Melbourne to Sheffield - Carmel Pezaro
Use of MRI to Risk Stratify Patients with Prostate Cancer- Simpa Salami
Focal Therapy - Art Rastinehad
Identifying High Risk Patients with Prostate Cancer - Adam Kibel
Practice Patterns of Active Surveillance in Prostate Cancer - Matt Cooperberg
Active Surveillance: Recent Findings and Case Studies - Laurence Klotz
Incremental Value of 11C Acetate Over 68Ga-PSMA PET CT for Prostate Cancer Patients - Sirong Chen
Laser Focal Therapy in Prostate Cancer - John Feller
Genetic Screening for Patients with Prostate Cancer - Todd Morgan
Prostate Cancer Awareness Month - David Penson
Prostate Cancer Screening is a Shared Decision - Matthew Cooperberg
The Optimal Treatment for Gleason Score 9-10 Prostate Cancer - Daniel Spratt
Personal Prostate Cancer Journey to Raise Funds and Awareness- Sanford Siegel
Androgen Receptor-Targeted Treatments for Prostate Cancer: 35 Years' Progress with Antiandrogens - E. David Crawford
Screening for Prostate Cancer in African American Men - Judd Moul
The United States Preventive Services Task Force PSA Screening Recommendations- David Penson
Novel Circulating Tumor Cells Blood Assay for the Clarification of 4-10 ng/mL PSA Results - See-Tong Pang
The Key to Prostate Cancer, a Book Club Review with Mark Scholz
Optimizing Care in Patients with High Risk Prostate Cancer - Interview with Edward Schaeffer
Use of Conservative Management for Low-Risk Prostate Cancer - Interview with Stacy Loeb
Personalization of Therapy to Optimize Outcomes for Men with Prostate Cancer - Interview with Felix Feng
Geriatric Assessment of Men with Prostate Cancer - Alicia Morgans
Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton
Discussion on Prostate Rectum Spacing in Radiation Therapy - Lawrence Karsh
The Virility Paradox, A Book Review with Charles Ryan
Under the Knife, A Book Review with Kelly Parsons
GayBiProstate Study: Expanding Quality of Life and Understanding Sexual Function Post Treatment - Bernard Lee